Discontinued — last reported Q4 '25
Investing Cash Flow
InvestingEli Lilly Investing Cash Flow increased by 6.0% to -$2.80B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 45.9%, from -$1.92B to -$2.80B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 41.2% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2007
Last reportedQ4 2025
How to read this metric
A large negative value is typical for growing companies, indicating they are spending more on assets and acquisitions than they are receiving from sales.
Detailed definition
The aggregate net change in cash resulting from all investing activities, including capital expenditures, business acqui...
Peer comparison
For tech giants, this is often the largest area of cash outflow after shareholder returns, driven by data center expansion.
Metric ID:
cf_net_cash_from_investingHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$483.30M | -$616.50M | -$379.00M | -$1.01B | -$463.90M | -$923.40M | -$860.50M | -$688.80M | -$459.10M | -$3.08B | -$2.92B | -$1.18B | -$2.20B | -$4.00B | -$1.92B | -$3.35B | -$1.83B | -$2.98B | -$2.80B |
| QoQ Change | — | -27.6% | +38.5% | -167.5% | +54.2% | -99.1% | +6.8% | +20.0% | +33.3% | -571.0% | +5.1% | +59.7% | -86.7% | -82.1% | +52.0% | -74.6% | +45.3% | -62.5% | +6.0% |
| YoY Change | — | — | — | — | +4.0% | -49.8% | -127.0% | +32.1% | +1.0% | -233.6% | -239.8% | -71.0% | -378.9% | -30.0% | +34.3% | -184.7% | +16.5% | +25.5% | -45.9% |
Range-$4.00B – -$379.00M
CAGR+47.8%
Avg YoY Growth-83.1%
Median YoY Growth-45.9%
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Eli Lilly's investing cash flow?
- Eli Lilly (LLY) reported investing cash flow of -$2.80B in Q4 2025.
- How has Eli Lilly's investing cash flow changed year-over-year?
- Eli Lilly's investing cash flow decreased by 45.9% year-over-year, from -$1.92B to -$2.80B.
- What is the long-term trend for Eli Lilly's investing cash flow?
- Over 4 years (2021 to 2025), Eli Lilly's investing cash flow has grown at a 41.2% compound annual growth rate (CAGR), from -$2.76B to -$10.97B.
- What does investing cash flow mean?
- The total net amount of money spent on or received from long-term investments and business assets.